Login / Signup
Arijit Nandi
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Interstitial Lung Disease
Rheumatoid Arthritis
Epithelial Mesenchymal Transition
Genome Wide Identification
Top Venues
Life (Basel, Switzerland)
Expert opinion on drug discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Arijit Nandi
,
Anwesha Das
,
Yadu Nandan Dey
,
Kuldeep K Roy
The Abundant Phytocannabinoids in Rheumatoid Arthritis: Therapeutic Targets and Molecular Processes Identified Using Integrated Bioinformatics and Network Pharmacology.
Life (Basel, Switzerland)
13 (3) (2023)
Arijit Nandi
,
Anwesha Das
,
Yadu Nandan Dey
,
Kuldeep K Roy
The Abundant Phytocannabinoids in Rheumatoid Arthritis: Therapeutic Targets and Molecular Processes Identified Using Integrated Bioinformatics and Network Pharmacology.
Life (Basel, Switzerland)
13 (3) (2023)
Arijit Nandi
,
Anwesha Das
,
Yadu Nandan Dey
,
Kuldeep K Roy
The Abundant Phytocannabinoids in Rheumatoid Arthritis: Therapeutic Targets and Molecular Processes Identified Using Integrated Bioinformatics and Network Pharmacology.
Life (Basel, Switzerland)
13 (3) (2023)
Salma Haj-Yahia
,
Arijit Nandi
,
Raphael I Benhamou
Targeted Degradation of Structured RNAs via Ribonuclease-Targeting Chimeras (RiboTacs).
Expert opinion on drug discovery
(2023)